High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1.
暂无分享,去创建一个
C. Gabel | J. Mcneish | G. Chimini | C. Broccardo | O. Francone | L. Royer | J. D. de Wet | C. Aldinger | M. Roach | R. Aiello | T. Turi | D. Guyot | K. L. Hoppe | Jeffery de Wet
[1] T. Langmann,et al. Transport of lipids from Golgi to plasma membrane is defective in Tangier disease patients and Abc1-deficient mice , 2000, Nature Genetics.
[2] J. Warrington,et al. A high-density probe array sample preparation method using 10- to 100-fold fewer cells , 1999, Nature Biotechnology.
[3] T. Langmann,et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease , 1999, Nature Genetics.
[4] J. Piette,et al. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1 , 1999, Nature Genetics.
[5] C. Sensen,et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency , 1999, Nature Genetics.
[6] M C Phillips,et al. Cell cholesterol efflux: integration of old and new observations provides new insights. , 1999, Journal of lipid research.
[7] C. Fielding,et al. Secretion of lecithin:cholesterol acyltransferase by brain neuroglial cell lines. , 1999, Biochemical and biophysical research communications.
[8] A. Tall,et al. Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels. , 1999, The Journal of clinical investigation.
[9] E. Rubin,et al. Lower Plasma Levels and Accelerated Clearance of High Density Lipoprotein (HDL) and Non-HDL Cholesterol in Scavenger Receptor Class B Type I Transgenic Mice* , 1999, The Journal of Biological Chemistry.
[10] J. Mcneish,et al. Expression of human lecithin:cholesterol acyltransferase in transgenic mice: effects on cholesterol efflux, esterification, and transport. , 1997, Journal of lipid research.
[11] B. Verrier,et al. ABC1, an ATP Binding Cassette Transporter Required for Phagocytosis of Apoptotic Cells, Generates a Regulated Anion Flux after Expression in Xenopus laevis Oocytes* , 1997, The Journal of Biological Chemistry.
[12] O. Francone,et al. Increased prebeta-HDL levels, cholesterol efflux, and LCAT-mediated esterification in mice expressing the human cholesteryl ester transfer protein (CETP) and human apolipoprotein A-I (apoA-I) transgenes. , 1996, Journal of lipid research.
[13] B. Koller,et al. A new embryonic stem cell line from DBA/1lacJ mice allows genetic modification in a murine model of human inflammation. , 1995, Experimental cell research.
[14] D. L. Wilson,et al. Hyper- and hypo-responsiveness to dietary fat and cholesterol among inbred mice: searching for level and variability genes. , 1995, Journal of lipid research.
[15] G. Francis,et al. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease. , 1995, The Journal of clinical investigation.
[16] J. Wright,et al. Immunomodulatory Functions of Surfactant , 1995, Physiological reviews.
[17] F. Denizot,et al. Cloning of two novel ABC transporters mapping on human chromosome 9. , 1994, Genomics.
[18] C. Higgins,et al. ABC transporters: from microorganisms to man. , 1992, Annual review of cell biology.
[19] C. Fielding,et al. Distribution and functions of lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in plasma lipoproteins. Evidence for a functional unit containing these activities together with apolipoproteins A-I and D that catalyzes the esterification and transfer of cell-derived choleste , 1989, The Journal of biological chemistry.
[20] Mario R. Capecchi,et al. Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes , 1988, Nature.
[21] C. Fielding,et al. Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein. , 1988, Biochemistry.
[22] R. Gregg,et al. In vivo metabolism of proapolipoprotein A-I in Tangier disease. , 1987, The Journal of clinical investigation.
[23] M. Brown,et al. A receptor-mediated pathway for cholesterol homeostasis. , 1986, Science.
[24] E. Schaefer. Clinical, biochemical, and genetic features in familial disorders of high density lipoprotein deficiency. , 1984, Arteriosclerosis.
[25] A. Keys. ALPHA LIPOPROTEIN (HDL) CHOLESTEROL IN THE SERUM AND THE RISK OF CORONARY HEART DISEASE AND DEATH , 1980, The Lancet.
[26] D. Thelle,et al. THE TROMSØHEART-STUDY HIGH-DENSITY LIPOPROTEIN AND CORONARY HEART-DISEASE: A PROSPECTIVE CASE-CONTROL STUDY , 1977, The Lancet.
[27] S. Isomura,et al. CONTACT INFECTION FROM LIVE VARICELLA VACCINE RECIPIENTS , 1976, The Lancet.
[28] M. Sheridan. Letter: The handicapped family. , 1975 .
[29] Zilversmit Db,et al. Validation of a dual-isotope plasma ratio method for measurement of cholesterol absorption in rats. , 1974 .
[30] V. Ferrans,et al. The pathology of Tangier disease. A light and electron microscopic study. , 1975, The American journal of pathology.